<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39323904</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-6022</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>American heart journal plus : cardiology research and practice</Title><ISOAbbreviation>Am Heart J Plus</ISOAbbreviation></Journal><ArticleTitle>Understanding the link between COVID-19, blood pressure and obesity: Perspectives from the New Orleans experience.</ArticleTitle><Pagination><StartPage>100460</StartPage><MedlinePgn>100460</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100460</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ahjo.2024.100460</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fusco</LastName><ForeName>Dahlene</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Tulane University School of Medicine, New Orleans, LA, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Medical Center, New Orleans, LA, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tulane Medical Center, New Orleans, LA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Sharon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Tulane University School of Medicine, New Orleans, LA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theberge</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Tulane University, New Orleans, LA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pulapaka</LastName><ForeName>Anuhya S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Tulane University School of Medicine, New Orleans, LA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rittmeyer</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Tulane University School of Medicine, New Orleans, LA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zha</LastName><ForeName>Yitian</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Tulane University School of Medicine, New Orleans, LA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maylin</LastName><ForeName>Marlowe</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Tulane University School of Medicine, New Orleans, LA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rothwell</LastName><ForeName>W Ben</ForeName><Initials>WB</Initials><AffiliationInfo><Affiliation>Tulane University School of Medicine, New Orleans, LA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adhikari</LastName><ForeName>Prateek</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Tulane Medical Center, New Orleans, LA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reynaud</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Tulane University School of Medicine, New Orleans, LA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferdinand</LastName><ForeName>Keith</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Tulane University School of Medicine, New Orleans, LA, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Medical Center, New Orleans, LA, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tulane Medical Center, New Orleans, LA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drouin</LastName><ForeName>Arnaud</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tulane University School of Medicine, New Orleans, LA, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Medical Center, New Orleans, LA, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tulane Medical Center, New Orleans, LA, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am Heart J Plus</MedlineTA><NlmUniqueID>101779333</NlmUniqueID><ISSNLinking>2666-6022</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute COVID-19</Keyword><Keyword MajorTopicYN="N">Clinical predictor of outcomes</Keyword><Keyword MajorTopicYN="N">Obesity</Keyword><Keyword MajorTopicYN="N">Pre-COVID hypertension</Keyword><Keyword MajorTopicYN="N">Systolic blood pressure</Keyword></KeywordList><CoiStatement>Keith Ferdinand is an Editorial Board Member/Associate Editor for American Heart Journal plus and was not involved in the editorial review or the decision to publish this article. Arnaud Drouin and Dahlene Fusco declare the following financial interests/personal relationships which may be considered as potential competing interests: AD and DF have received investigator-initiated study awards from 10.13039/100005564Gilead Sciences, have served as site investigators for COVID-19 clinical trials sponsored by 10.13039/100005564Gilead, 10.13039/100009857Regeneron, and Metro Biotech LLC. DF has served on Advisory Boards for 10.13039/100005564Gilead Sciences and AXCELLA.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>10</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>4</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39323904</ArticleId><ArticleId IdType="pmc">PMC11423287</ArticleId><ArticleId IdType="doi">10.1016/j.ahjo.2024.100460</ArticleId><ArticleId IdType="pii">S2666-6022(24)00103-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dahlene Fusco S.L., Theberge Marc, Pulapaka Anuhya S., Rittmeyer William, Zha Yitian, Marlowe Maylin W., Rothwell Ben, Adhikari Prateek, Raynaud Peter, Ferdinand Keith, Drouin Arnaud. MedRxiv; 2024. Admission Systolic Blood Pressure and Obesity Correlate With Fatal and Severe Acute COVID-19 in the Population of New Orleans, LA.</Citation></Reference><Reference><Citation>Zeller M., et al. Emergence of an early SARS-CoV-2 epidemic in the United States. Cell. 2021;184(19):4939–4952 e15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8313480</ArticleId><ArticleId IdType="pubmed">34508652</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarado F., et al. Influence of neighborhood-level social determinants of health on a heart-healthy lifestyle among Black church members: a mixed-methods study. Am. Heart J. Plus. 2023;27</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10946005</ArticleId><ArticleId IdType="pubmed">38511101</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J., et al. Understanding the role of left and right ventricular strain assessment in patients hospitalized with COVID-19. Am. Heart J. Plus. 2021;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8168299</ArticleId><ArticleId IdType="pubmed">34095889</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicenzi M., et al. The liaison between respiratory failure and high blood pressure: evidence from COVID-19 patients. Eur. Respir. J. 2020;56(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7241109</ArticleId><ArticleId IdType="pubmed">32430432</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacher J., et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch. Intern. Med. 2000;160(8):1085–1089.</Citation><ArticleIdList><ArticleId IdType="pubmed">10789600</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheblawi M., et al. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ. Res. 2020 May 8;126(10):1456–1474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7188049</ArticleId><ArticleId IdType="pubmed">32264791</ArticleId></ArticleIdList></Reference><Reference><Citation>Suryamohan K., et al. Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2. Commun. Biol. 2021;4(1):475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8041869</ArticleId><ArticleId IdType="pubmed">33846513</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapolyai M., et al. High prevalence of liddle syndrome phenotype among hypertensive US Veterans in Northwest Louisiana. J. Clin. Hypertens. (Greenwich) 2010;12(11):856–860.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8816470</ArticleId><ArticleId IdType="pubmed">21054772</ArticleId></ArticleIdList></Reference><Reference><Citation>Gainer J.V., et al. Increased sensitivity to bradykinin among African Americans. J. Allergy Clin. Immunol. 1996;98(2):283–287.</Citation><ArticleIdList><ArticleId IdType="pubmed">8757204</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J.B., et al. Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol. J. Clin. Hypertens. (Greenwich) 2020;22(10):1780–1788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7722152</ArticleId><ArticleId IdType="pubmed">32937008</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene C., et al. Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat. Neurosci. 2024;27(3):421–432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10917679</ArticleId><ArticleId IdType="pubmed">38388736</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>